Induction of complete remission of acute myeloid leukaemia by pegylated interferon-α-2a in a patient with transformed primary myelofibrosis

被引：24
作者：
Berneman, Zwi N. [1 ,2 ]
Anguille, Sebastien [1 ,2 ]
Van Marck, Veerle [3 ]
Schroyens, Wilfried A. [1 ,2 ]
Van Tendeloo, Viggo F. [2 ]
机构：
[1] Univ Antwerp Hosp, Div Haematol, Edegem, Belgium
[2] Univ Antwerp, Vaccine & Infect Dis Inst, B-2020 Antwerp, Belgium
[3] Univ Antwerp Hosp, Div Pathol, Edegem, Belgium
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2010年 / 149卷 / 01期
关键词：
interferon; acute leukaemia; myelofibrosis; leukaemia therapy; CELLS IN-VITRO; EXPERIENCE; GENE;
D O I：
10.1111/j.1365-2141.2009.08029.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：152 / 155
页数：4
相关论文
共 10 条
[1]   Continuous delivery of human type I interferons (α/β) has significant activity against acute myeloid leukemia cells in vitro and in a xenograft model [J].
Benjamin, Reuben ;
Khwaja, Asim ;
Singh, Nalini ;
McIntosh, Jenny ;
Meager, Anthony ;
Wadhwa, Meenu ;
Streck, Christian ;
Ng, Catherine ;
Davidoff, Andrew M. ;
Nathwani, Amit C. .
BLOOD, 2007, 109 (03) :1244-1247
[2]  
Geng YP, 1995, CYTOKINES MOL THER, V1, P289
[3]   PEG-IFN-α-2a therapy in patients with myelofibrosis [J].
Ianotto, Jean-Christophe ;
Kiladjian, Jean-Jacques ;
Demory, Jean-Louis ;
Roy, Lydia ;
Boyer, Francoise ;
Rey, Jerome ;
Dupriez, Brigitte ;
Berthou, Christian ;
Abgrall, Jean-Francois .
BRITISH JOURNAL OF HAEMATOLOGY, 2009, 146 (02) :223-225
[4]   Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera [J].
Kiladjian, Jean-Jacques ;
Cassinat, Bruno ;
Chevret, Sylvie ;
Turlure, Pascal ;
Cambier, Nathalie ;
Roussel, Murielle ;
Bellucci, Sylvia ;
Grandchamp, Bernard ;
Chomienne, Christine ;
Fenaux, Pierre .
BLOOD, 2008, 112 (08) :3065-3072
[5]   Peginterferon alfa-2a: A review of approved and investigational uses [J].
Matthews, SJ ;
McCoy, C .
CLINICAL THERAPEUTICS, 2004, 26 (07) :991-1025
[6]   Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases [J].
Mesa, RA ;
Li, CY ;
Kettering, RP ;
Schroeder, GS ;
Knudson, RA ;
Tefferi, A .
BLOOD, 2005, 105 (03) :973-977
[7]   The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia [J].
Ogawa, H ;
Tamaki, H ;
Ikegame, K ;
Soma, T ;
Kawakami, M ;
Tsuboi, A ;
Kim, EH ;
Hosen, N ;
Murakami, M ;
Fujioka, T ;
Masuda, T ;
Taniguchi, Y ;
Nishida, S ;
Oji, Y ;
Oka, Y ;
Sugiyama, H .
BLOOD, 2003, 101 (05) :1698-1704
[8]   Mechanisms of type-I- and type-II-interferon-mediated signalling [J].
Platanias, LC .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (05) :375-386
[9]  
ROHATINER AZS, 1983, CANCER CHEMOTH PHARM, V11, P56
[10]   Antitumor effect of interferon-α on U937 human acute leukemia cells in vitro and its molecular mechanism [J].
Zhang Chun ;
Cu Guohui ;
Chen Yan ;
Fan Ke .
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2007, 27 (05) :513-515
1